Potrero Hill Therapeutics

Potrero Hill Therapeutics is a biotech company. It offers humanized monoclonal antibody (mAb) therapeutics for the treatment of solid tumors. In addition, the company develops molecule inhibitors for the treatment of NASH, dyslipidemia, type 2 diabetes, and other metabolic diseases, as well as immuno-oncology agents for the treatment of solid tumors and hematologic malignancies.